ArticleMikrochimica acta2026
An Fe single-atom nanozyme-sensitized RPA-CRISPR/Cas12a biosensor for the early detection of potential microcystins-producing cyanobacteria.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Harmful cyanobacteria are capable of producing hepatotoxic microcystins (MCs), which pose a significant risk to both aquatic ecosystems and public health. Since cyanobacterial strains that produce MCs harbor the mcy gene cluster, monitoring and analyzing the levels of the mcy gene is critical for identifying potential MCs-producing strains and assessing periods of elevated risk. In this study, Fe single-atom nanozymes (Fe SANs) with enhanced peroxidase-like (POD) activity were synthesized, which were then used to form a Fe SANs-DNA-magnetic bead complex (Fe SANs-DNA-MB). By integrating pre-amplification via recombinase polymerase amplification (RPA), trans-cleavage by CRISPR/Cas12a, and catalytic activity by Fe SANs, a novel triple signal amplification biosensor was developed for the detection of the microcystin synthase gene E (mcyE), a critical biomarker for MCs-producing cyanobacteria. The biosensor demonstrated significantly improved analytical performance, achieving a broad dynamic rangefor mcyE detection from 0.1 pM to 20 nM (R2 = 0.99), with a low limit of detection (LOD) of 0.05 pM. Furthermore, the biosensor provides high accuracy, as evidenced by spiked recoveries of mcyE in natural lake water samples ranging from 97.93% to 103.3%. It also enabled the selective identification of the mcyE gene in toxin-producing cyanobacterial strains (FACHB-905 and FACHB-979), thereby effectively distinguishing between toxin-producing and non-toxin-producing cyanobacteria. This innovative approach advances the field of molecular biosensing by providing a highly sensitive platform for the quantitative detection of the mcyE gene, facilitating accurate monitoring of MCs-producing cyanobacteria in environmental contexts. The method holds considerable promise for enhancing water quality management and protecting public health.
Indexed as
Identifiers
42171807What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.